Ward; Simon E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ward; Simon E..The latest application filed is for "tetrazole compounds as calcium channel blockers".

Company Profile

0.9.11

Ward; Simon E. - Cambridge GB
Ward; Simon E. - Harlow GB
Ward; Simon E - Harlow GB
Ward; Simon E. - Essex GB
Ward, Simon E - Harlow Essex GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tetrazole compounds as calcium channel blockers Grant 9,750,719 - Beswick , et al. September 5, 2	2017-09-05
Tetrazole Compounds As Calcium Channel Blockers App 20160015687 - BESWICK; Paul ; et al.	2016-01-21
Tetrazole compounds as calcium channel blockers Grant 9,115,132 - Beswick , et al. August 25, 2	2015-08-25
Tricyclic substituted benzenesulfonamide piperazine derivatives as CAV2.2 calcium channel blockers Grant 8,933,132 - Norton , et al. January 13, 2	2015-01-13
Piperazine Derivatives As Cav2.2 Calcium Channel Blockers App 20140038976 - Norton; David ; et al.	2014-02-06
Tetrazole Compounds As Calcium Channel Blockers App 20130210796 - Beswick; Paul ; et al.	2013-08-15
Compounds which potentiate the AMPA receptor and uses thereof in medicine Grant 8,173,820 - Bertheleme , et al. May 8, 2	2012-05-08
Pyrazolo[1,5-A]pyrimidine-carbonyl-piperazine derivatives Grant 8,093,249 - Heer , et al. January 10, 2	2012-01-10
Compounds which Potentiate the AMPA Receptor and Uses Thereof in Medicine App 20110021578 - Bertheleme; Nicolas ; et al.	2011-01-27
Novel Derivatives App 20100016330 - Heer; Jag Paul ; et al.	2010-01-21
Heterocyclic compounds possessing affinity at 5HT.sub.1 -type receptors and use thereof in therapy Grant 7,244,726 - Harrington , et al. July 17, 2	2007-07-17
Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors Grant 7,214,674 - Ward May 8, 2	2007-05-08
Piperidine and piperazine derivatives possessing affinity at 5ht-1 type receptors App 20050176724 - Flynn, Sean F. ; et al.	2005-08-11
Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors App 20050153974 - Ward, Simon E.	2005-07-14
Compound possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders App 20050107410 - Smith, Paul W ; et al.	2005-05-19
Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy App 20050085458 - Harrington, Frank P ; et al.	2005-04-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.